Rozdil Capital
C$0.2200
0
+C$0.00+0%Monday 15:47
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Thiogenesis Therapeutics, Corp., a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of a range of unmet genetic and central nervous system diseases. Its lead product candidate under development is TTI-0102, a prodrug consisting of cysteamine and pantetheine for use in the treatment of mitochondrial encephalopathy lactic acidosis and stroke. The company is headquartered in Toronto, Canada.
Show More
CEO
Mr. Brook G. Riggins C.F.A.
Country
Canada
ISIN
CA7810671031
Listings
0 Comments
Share your thoughts
FAQs
What is Rozdil Capital stock price today?▼
The current price of ROZ-P.V is C$0.22 CAD — it has increased by +0% in the past 24 hours. Watch Rozdil Capital stock price performance more closely on the chart.
What is Rozdil Capital stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on TSX Venture Exchange exchange Rozdil Capital stocks are traded under the ticker ROZ-P.V.
In which sector is Rozdil Capital located?▼
Rozdil Capital operates in the Finance & Payments sector.
When did Rozdil Capital complete a stock split?▼
Rozdil Capital has not had any recent stock splits.
Where is Rozdil Capital headquartered?▼
Rozdil Capital is headquartered in Toronto, Canada.